Navigation Links
Breast density change linked to cancer development in WHI hormone replacement study
Date:4/21/2010

Washington, DC --An increase in breast density appears to be the culprit behind an increase of breast cancer found in women participating in the estrogen and progestin therapy study, a part of the Women's Health Initiative (WHI). That is the finding of a new WHI analysis led by Celia Byrne, PhD, assistant professor at Georgetown Lombardi Comprehensive Cancer Center, and presented during the AACR 101st Annual Meeting 2010 in Washington, DC.

The WHI was launched in 1991 and consisted of a set of clinical trials and an observational study, which together involved 161,808 generally healthy postmenopausal women. One of the clinical trials examined the health effects of estrogen plus progestin therapy (EPT). The study was stopped early in 2002 because of an increased cancer risk found in those taking EPT. In the current analysis, researchers set out to determine if a change in mammographic density for EPT users could explain the increased breast cancer risk.

"In fact, that's exactly what we found," says Byrne. She adds that mammographic density is one of the strongest predictors of breast cancer risk suggesting that it might be a useful intermediate marker of change in breast cancer risk.

For the analysis, researchers obtained mammograms from study participants taken before they were randomized to the EPT or placebo arm of the WHI study. They also obtained mammograms from 97 women in the EPT arm who later developed invasive breast cancer. The mammograms (of the contralateral breast) were taken a year after they were randomized. In addition, the researchers collected mammograms from 77 women, also taken a year after they were randomized to the placebo arm. Finally, mammograms from a "random side" were collected for 733 health controls. The mammograms were digitized. Four experienced readers blinded to treatment and outcome assessed mammographic density, the proportion of the breast area appearing dense on the mammogram. The risk associated with both baseline mammographic density and change in mammographic was evaluated. The four readers' results were highly correlated.

A decline in mammographic density was seen in more than half (57 percent) of the women in the placebo group compared with a 16 percent decrease in the EPT arm. Eight-four percent of women in the EPT arm had increased mammographic density compared to 47 percent of the women in the placebo group.

In the EPT arm, both the baseline and change in mammographic density were significantly associated with breast cancer risk. Using these mammograms, researchers could "predict" those who would go on to develop breast cancer. Among the 20 percent of women with the greatest increase in mammographic density in the EPT arm of the study, breast cancer risk was more than tripled (3.6-fold) compared to the 20 percent increased risk in the group with the lowest increase or decrease in density.

"The overall result within this sub-study for the effect of EPT on breast cancer risk compared to placebo was similar to that of the WHI findings," says Byrne. The researchers reported an overall 24 percent increased breast cancer risk for those in the EPT arm.

"For women using hormone replacement therapy with estrogen and progestin, breast density is a factor that a physician should consider when tracking their breast health," concludes Byrne. "For general screening, breast density might one day be used to help determine mammograms that demonstrate uncertainty about a visual anomaly."


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Studies Confirm Link Between Breast Density and Cancer
2. Change in breast density over time provides clues about breast cancer risk
3. Earlier Detection of Breast Cancer May Be Possible
4. Steady Weight Gain Boosts Late-Life Breast Cancer Risk
5. Increased EGFR levels may be an early marker of breast cancer
6. Body Mass Index gain throughout adulthood may increase risk of postmenopausal breast cancer
7. Protein plays a critical role in the development of aggressive breast cancer
8. New Guidelines Issued on Hormone Receptor Testing for Breast Cancer
9. Raloxifene, Tamoxifen Both Guard Against Breast Cancer
10. Supplements Might Reduce Breast Cancer Risk
11. Routine breast cancer biopsy might predict lymph node cancer spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Mediaplanet is ... Wound Care" campaign in USA Today, which will educate readers on how to take ... the campaign, a large focus is placed on melanoma. Dancing with the Stars professional, ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... , ... May 26, 2017 , ... After raising nearly ... Top gadget will continue to be available at a discounted crowdfunding price on ... stress wherever they are, I also wanted to bring a fidget toy to the ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “When the Stars ... Home” is the creation of published author Laura Weigel Douglas, an avid reader who ... in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t be ...
(Date:5/26/2017)... ... , ... Water damage to the flooring of several classrooms at The Fort ... with a number of critical issues to address before students could return to classes. ... little or no disruption to class schedules. Second, the project had to comply with ...
Breaking Medicine News(10 mins):
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
(Date:5/10/2017)... , May 10, 2017 Radiology has become ... its costs have also spiraled to the number one ... to radiology than ever before as the most complete ... a patient with lower back pain an MRI may ... reason for pain, resulting in entirely different treatment protocols.  ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: